3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Primary Myelofibrosis
19
Myeloproliferative Disorders
16
Polycythemia Vera
10
Leukemia
8
Leukemia, Myeloid, Acute
7
Breast Neoplasms
6
Pancreatic Neoplasms
5
Myelodysplastic Syndromes
5
Hematologic Diseases
5
Thrombocythemia, Essential
4
Multiple Myeloma
4
Bone Marrow Diseases
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Neoplasms
3
Myelodysplastic-Myeloproliferative Diseases
3
Leukemia, Myelomonocytic, Chronic
3
Graft vs Host Disease
3
Thrombocytosis
2
Prostatic Neoplasms
2
Lymphoma, Large B-Cell, Diffuse
2
Lymphoma, Follicular
2
Lymphoma
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Bronchiolitis Obliterans Syndrome
2
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Preleukemia
1
Precancerous Conditions
1
Pathologic Complete Response
1
Interventions
Cyclophosphamide
82
fludarabine phosphate
68
Mycophenolic Acid
59
Whole-Body Irradiation
52
Peripheral Blood Stem Cell Transplantation
51
Tacrolimus
49
Melphalan
44
Etoposide
42
Busulfan
39
fludarabine
36
Rituximab
36
Filgrastim
36
Granulocyte Colony-Stimulating Factor
35
Brentuximab Vedotin
33
Cyclosporine
32
Doxorubicin
28
Methotrexate
27
Antilymphocyte Serum
27
Radiotherapy
24
Dacarbazine
19
Vinblastine
18
Nivolumab
18
Cytarabine
18
Prednisone
16
Carmustine
16
thymoglobulin
15
Stem Cell Transplantation
15
Sirolimus
15
Alemtuzumab
14
Vincristine
13
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Hodgkin Disease
×
ruxolitinib
×
Clear all
No trials found.